Drugs / VCL-2510
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00377494 | ? → Jul 2008 | Plasmodium falciparum malaria | National Institute of Allergy and Infectious Diseases (NIAID) | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VCL-2510 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00377494 ↗ |
| Modality | Vaccine | “DNA malaria vaccine” NCT00377494 ↗ |
| Route | Intramuscular | “DNA malaria vaccine intramuscularly (IM)” NCT00377494 ↗ |